|
| 
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
 |
Sandoz to market Rockeby's Pepp in China
 |
|
| Rockeby biomed, a Singapore-based healthcare company has appointed Sandoz China (Sandoz), a subsidiary of Shanghai Novartis, as its exclusive distributor for Pepp in China. Sandoz is marketing Pepp as a food product |
|
|
|
|
|
GXS launches China eHealthcare Exchange
|
|
| Based in Gaithersburg, GXS, a provider of B2B e-commerce solutions, announced the launch of China eHealthcare Exchange, a B2B e-commerce platform for China's pharmaceutical industry |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
|
|
We are building a bio-engineering company:CSKI
|
|
| China Sky One Medical (CSKI), a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal kit products |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
|
|
3Sbio promotes Dr David Chen as COO
|
|
| 3Sbio, a China-based biotechnology company, has appointed Dr David Chen to the newly created role of Executive Vice President and Chief Operating Officer (COO) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
Over 1200 firms attend API & INTERPHEX China
|
|
| The event attracted over 1200 domestic and oversees enterprises and over 30,000 professional visitors to Dalian, ranked as the 7th top Chinese cities in terms of competitive strength and supportive government authority |
|
|
|
|
|
China Medicine to represent Guangzhou at BIO 2008
|
|
| China Medicine, a distributor and developer of ethical and OTC drugs in China was selected by the Guangzhou Technology Bureau to represent Guangzhou city's biotechnology industry at BIO International Convention |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
Reishi mushroom, green tea extracts slow sarcoma
|
|
| Chinese scientists have found that combining the active ingredients in the reishi mushroom and the green tea create synergetic effects that inhibit the growth of tumors and delay the time of death in mice with sarcomas
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
Knee implant market booming in China: Millennium Research
|
|
| The sales of reconstructive knee implants will skyrocket in China, at an almost 25% compound annual growth rate from 2007 through 2012. Strong economic growth, favorable demographics, and an improving quality of life, will drive this market |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
